Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase) |
|
ABC-TC3364 |
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-PB Plasma is obtained by centrifuging Chronic Myeloid Leukemia peripheral blood. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia plasma is available in the chronic phase and accelerated or blast crisis phase. |
Igg Antibody Laboratories manufactures the igg chronic antibiody reagents distributed by Genprice. The Igg Chronic Antibiody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Chronic Group: Antibiody
Human Chronic Myeloid Leukemia PB Plasma (Chronic Phase) |
|
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-PB Plasma is obtained by centrifuging Chronic Myeloid Leukemia peripheral blood. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia plasma is available in the chronic phase and accelerated or blast crisis phase. |
Human Chronic Myeloid Leukemia Bone Marrow Plasma (Chronic Phase) |
|
AcceGen |
1 vial |
Ask for price |
|
|
|
Description: Chronic Myeloid Leukemia-Bone Marrow plasma is obtained by centrifugation of the Chronic Myeloid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia-Bone Marrow plasma is available in chronic phase and accelerated or blast crisis phase. |
Antibiody information
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380715-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380715-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380715-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380716-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380716-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380716-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380716-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) |
|
MBS4380716-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|
BNC702035-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|
BNC702035-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF770 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|
BNC702046-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|
BNC702046-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF770 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|
BNC802035-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|
BNC802035-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|
BNC802046-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody |
|
BNC802046-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL |
ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody |
|
BNC612035-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF660R conjugate, Concentration: 0.1mg/mL |